financetom
Business
financetom
/
Business
/
Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma
Dec 16, 2024 5:33 AM

08:05 AM EST, 12/16/2024 (MT Newswires) -- Soligenix ( SNGX ) said Monday it has begun patient enrollment for its phase 3 study of its experimental therapy, HyBryte, to treat cutaneous T-cell lymphoma or CTCL.

The company said the study builds on previous phase 3 results and additional supportive research.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Palantir Stock Is Trading Higher Thursday: What's Going On?
Palantir Stock Is Trading Higher Thursday: What's Going On?
May 26, 2025
Palantir Technologies Inc ( PLTR ) shares are trading higher Thursday. The stock appears to be benefiting from an Army contact modification announced after the market close on Wednesday. What Happened: Late Wednesday, the Department of Defense announced that it awarded Palantir ( PLTR ) a $795 million modification to a contract for its Maven Smart System software licenses. The...
Cognizant Expands Collaboration With Pegasystems to Accelerate AI-Driven Legacy Modernization
Cognizant Expands Collaboration With Pegasystems to Accelerate AI-Driven Legacy Modernization
May 26, 2025
01:56 PM EDT, 05/22/2025 (MT Newswires) -- Cognizant Technology Solutions ( CTSH ) said Thursday it is expanding its collaboration with Pegasystems ( PEGA ) to help enterprises modernize legacy systems using artificial intelligence. The partnership will combine Cognizant's agentic AI services with Pegasystems' ( PEGA ) Blueprint technology to address issues such as poor customer experience, inefficient processes, and...
WISeKey's SEALSQ Set to Buy France's IC'ALPS for $14.1 Million in Cash, Stock
WISeKey's SEALSQ Set to Buy France's IC'ALPS for $14.1 Million in Cash, Stock
May 26, 2025
01:52 PM EDT, 05/22/2025 (MT Newswires) -- WISeKey International ( WKEY ) unit SEALSQ ( LAES ) reached an agreement in principle to buy IC'ALPS, a French company specializing in application-specific integrated circuit design and supply, for 12.5 million euros ($14.1 million) in cash and stock. The agreement consists of 10 million euros in cash and 2.5 million euros in...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved